Abstract:The genome characteristics and structural functions of coding proteins correlate with the genetic diversity of the H1N1 virus, which aids in the understanding of its underlying pathogenic mechanism. In this study, analyses of the characteristic of the H1N1 virus infection-related genes, their biological functions, and infection-related reversal drugs were performed. Additionally, we used multi-dimensional bioinformatics analysis to identify the key genes and then used these to construct a diagnostic model for the H1N1 virus infection. There was a total of 169 differently expressed genes in the samples between 21 h before infection and 77 h after infection. They were used during the protein-protein interaction (PPI) analysis, and we obtained a total of 1725 interacting genes. Then, we performed a weighted gene co-expression network analysis (WGCNA) on these genes, and we identified three modules that showed significant potential for the diagnosis of the H1N1 virus infection. These modules contained 60 genes, and they were used to construct this diagnostic model, which showed an effective prediction value. Besides, these 60 genes were involved in the biological functions of this infectious virus, like the cellular response to type I interferon and in the negative regulation of the viral life cycle. However, 20 genes showed an upregulated expression as the infection progressed. Other 36 upregulated genes were used to examine the relationship between genes, human influenza A virus, and infection-related reversal drugs. This study revealed numerous important reversal drug molecules on the H1N1 virus. They included rimantadine, interferons, and shikimic acid. Our study provided a novel method to analyze the characteristic of different genes and explore their corresponding biological function during the infection caused by the H1N1 virus. This diagnostic model, which comprises 60 genes, shows that a significant predictive value can be the potential biomarker for the diagnosis of the H1N1 virus infection.

Design and Prediction of Multi-Epitope Gene of Influenza A Virus

Designing a multi-epitope influenza vaccine: an immunoinformatics approach

Identification and Analysis of B Cell Epitopes of Hemagglutinin of H1N1 Influenza Virus.

In silico design of a broad-spectrum multiepitope vaccine against influenza virus

Designing multi-epitope mRNA construct as a universal influenza vaccine candidate for future epidemic/pandemic preparedness

Recombinant Protein Comprising Multi-Neutralizing Epitopes Induced High Titer of Antibodies Against Influenza A Virus

Generation and Characterization of Monoclonal Antibodies Against the Hemagglutinin of H3N2 Influenza A Viruses.

Construction and Immunogenecity of a Multi-epitope Based SARS-CoV Gene Vaccine

Designing a multi-epitope vaccine against coxsackievirus B based on immunoinformatics approaches

Identification of a universal antigen epitope of influenza A virus using peptide microarray

Bioinformatics analysis of epitope-based vaccine design against the novel SARS-CoV-2

Integrated Analysis of Human Influenza A (H1N1) Virus Infectionrelated Genes to Construct a Suitable Diagnostic Model

Immunoinformatics design of multi-epitope peptide-based vaccine against Haemophilus influenzae strain using cell division protein

Predicton and Identification of Antigenic Epitopes in Genus-Specific Outer Membrane Proteins OmpL1 and LipL21 of Leptospira Interrogans

Identification of Linear Peptide Immunogens with Verified Broad-spectrum Immunogenicity from the Conserved Regions within the Hemagglutinin Stem Domain of H1N1 Influenza Virus

Multi-epitopevaccine design using an immunoinformaticsapproach for 2019 novelcoronavirus in China (SARS-CoV-2)

Proteolytic processing of the plum pox potyvirus polyprotein by the NIa protease at a novel cleavage site.

Multi-Epitope Vaccine Design Using an Immunoinformatic Approach for SARS-CoV-2

In Silico Design of A Dna-Based Hiv-1 Multi-Epitope Vaccine for Chinese Populations

Structure Modeling and Spatial Epitope Analysis for Ha Protein of the Novel H1n1 Influenza Virus

Highly Conserved M2e and Hemagglutinin Epitope-Based Recombinant Proteins Induce Protection Against Influenza Virus Infection